5 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated... Read more
Peter Salzmann
Kura Oncology
18 followers
Adverum Biotech
8 followers
SpringWorks Therapeutics
5 followers
REVOLUTION Medicines
5 followers
Viridian Therapeutics
2 followers
Fortis Life Sciences
1 follower
Vividion Therapeutics
1 follower
Biosynth
1 follower
Nkarta
1 follower
TMRW Life Sciences
1 follower
Thermo Fisher Scientific
168 followers
Explore companies